FDA grants approval for spirulina extract in beverages

EXBERRY

Friday, 11 November, 2022

FDA grants approval for spirulina extract in beverages

GNT has secured U.S. Food and Drug Administration (FDA) approval for the use of spirulina extract in beverages, enabling manufacturers to achieve vibrant blue shades while maintaining clean labels.

The company has developed a formulation technology that allows spirulina extract to remain temperature- and acid-stabilised in beverages. The EXBERRY Blue Beverage Solution is suitable for use in a wide range of applications including sports, energy and carbonated drinks, juice drinks, enhanced waters and alcoholic beverages below 20% ABV.

The Code of Federal Regulations (CFR) had previously only permitted the use of spirulina extract as a natural blue colouring ingredient in certain food products and powdered beverages. However, GNT successfully petitioned the FDA to amend the regulation to cover all non-alcoholic beverages and alcoholic beverages below 20% ABV. The update will come into effect on 13 December 2022.

This means the EXBERRY Blue Beverage Solution can be used as a replacement for Blue 1 in the majority of drink applications. It delivers a bright turquoise blue shade in acidified beverages with a pH range between 2.6 to 3.4 and can be combined with other concentrates to deliver hues including navy blue, violet and green.

Related News

Maple syrup explored as a potential sugar substitute

The potential health benefits of using pure maple syrup instead of sugar were explored in a...

Regularly eating nuts supports healthy lifespan, research finds

Regular consumption of nuts is associated with maintaining a healthy lifespan, research from a...

Colour supplier GNT recognised for sustainability

The recognition ranks the company among the top 3% in the food manufacturing industry.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd